Patent ID: 8293210

Claim:
A method of treating an ocular condition in an eye of a patient, comprising the step of placing an extruded, rod-shaped biodegradable intraocular implant in an eye of the patient, the implant comprising about 40% w/w brimonidine freebase and a biodegradable polymer matrix that releases an amount of brimonidine freebase effective to reduce a symptom of the ocular condition, wherein the implant is placed in the posterior of the eye; wherein the biodegradable polymer matrix comprises a 1:1 mixture of first and second biodegradable polymers; wherein the first biodegradable polymer is a poly (D,L-lactide) polymer having an average molecular weight of about 14,000 daltons; and wherein the second biodegradable polymer is a 50:50 poly (D,L-lactide-coglycolide) copolymer having an average molecular weight of about 11,700 daltons.